Recovery & Repair · commonly explored around recovery and tissue repair

TB-500 (Thymosin β4)

TB-500 is based on thymosin beta-4, a protein that helps cells move to where repair is needed. Animal studies link it to faster wound healing and tissue recovery, and it is a staple of recovery conversations.

Informational profile

No verified OnimaChain inventory for this profile.

Also known as Thymosin beta-4 · Tβ4 · TMSB4X · Thymosin β4 (synthetic fragment)

Sequence
SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES
Length
43 residues
MW
4921.46 Da computed
Product tags
actin binding · thymosin · g actin sequestering
Checked sources
5 sources in our record
Structure provenance
Sequence-derived illustration (not a measured structure)
See the simple guide ↓
PKSELTSIEPEKFEQEKSGNDEIDAQAKKMKSEDPKQLKTKET
Sequence-derived illustration (not a measured structure)

Meet TB-500 (Thymosin β4)

The short version, before the deep dive.

TB-500 is based on thymosin beta-4, a protein that helps cells move to where repair is needed. Animal studies link it to faster wound healing and tissue recovery, and it is a staple of recovery conversations.

PulseChain

What’s new with TB-500 (Thymosin β4)

Section B

The quick read

Section C

Research at a glance

A simple picture of the sources we have checked. More color means more records in that category—not that the product works better.

12345678910111213145record-dims

Filled = we have checked studies of that kind · hollow = none yet · dashed = not checked yet. This is a picture of what exists, not a score.

#DimensionVerifiedHow
1Cells in a dish (in vitro)2Checked studies done on cells in a lab dish.
2Mice1Checked studies whose title says it was done in mice.
3Rats1Checked studies whose title says it was done in rats.
4Other animals0 · none yetChecked studies whose title names another animal.
5People, observed0 · none yetChecked studies that watched people without a controlled trial.
6Single-person reports0 · none yetChecked reports about one patient (case reports).
7Phase I trial0 · none yetChecked early safety trials in a small group of people.
8Phase II trial0 · none yetChecked mid-size trials testing whether it works.
9Phase III trial0 · none yetChecked large trials, the kind regulators look at.
10Approved useNot checked yetNot checked yet — we have not connected regulator records.
11Repeated by othersNot checked yetNot checked yet — we do not track repeat studies yet.
12Separate research teamsBayrak BY · Cha HJ · Lim DS · Lachowicz JI · Gesteira TFHow many different senior authors the checked studies have. A rough stand-in for separate teams.
13How it works1Checked studies that looked at the mechanism, based on their summary.
14Years of research2020–2026From the oldest to the newest checked study.

Section D

What the sources looked at

These topics come only from sources in our record. We do not add a topic just because it is popular online.

  • A source studied

    Cell migration

    Checked sources: PMID 34170491

  • A source studied

    How cells move (actin)

    Checked sources: PMID 34170491

  • A source studied

    Wound-healing research

    Checked sources: PMID 42542926, PMID 41235866

  • People discuss

    Tissue-repair talk online

    Live community feeds are not connected yet.

Section E

Why people look it up

A plain-language starting point. This is not a promise that the product will cause a result.

recovery and tissue repair

See TB-500 (Thymosin β4) beside similar names.

The Portal of Tides lets you switch between a constellation, connection view, checked-source timeline, and topic map. It uses the products already in our collection—no fake customer counts.

Open Portal of Tides

Section F

What the record can tell us

A product page can show what was studied. It cannot promise what will happen to a person.

What we can show

  • Cell migration1 checked
  • How cells move (actin)1 checked
  • Wound-healing research2 checked

What we cannot promise

A lab result, animal study, online story, or product page cannot tell you what will happen to you. That question needs qualified medical guidance.

The short versionresearch is not a guaranteeWe keep the product, source, and claim separate so you can see which is which.

Section H

How far it has been tested

From cells in a dish, to mice, rats, bigger animals, people, proper trials, and finally regulator approval. The light stops where the checked studies stop.

cell migration

Tested as far as: Cells in a dish — and no further

  1. Cells in a disha checked study reached this stagereached
  2. Mouseno checked study has reached this stagestops here
  3. Ratno checked study has reached this stage
  4. Bigger animalno checked study has reached this stage
  5. Peopleno checked study has reached this stage
  6. Proper human trialno checked study has reached this stage
  7. Approved by regulatorsno checked study has reached this stage

Section I

How many separate teams

Ten papers from one lab are not ten separate confirmations.

Separate senior authors (a rough count of teams)

5 / 5 records

  • Bayrak BY1 record(s)
  • Cha HJ1 record(s)
  • Lim DS1 record(s)
  • Lachowicz JI1 record(s)
  • Gesteira TF1 record(s)

Universities, funding and who cites whom: not checked yet. PubMed’s summary does not include that, so it needs another data source.

Bayrak BYCha HJLim DSLachowicz JIGesteira TFbigger circle = more studies from that senior author · who cites whom: not checked yet

Section J

What doesn’t fit?

If a study disagrees, it goes here. We do not hide it.

No study we have checked pushes back yet

Studies that found nothing, disagree, or criticize the method will show up here once we add them. A study that only partly agrees is not the same as one that disagrees.

Section K

Timeline

What happened and when. Studies in one lane, real-world reports in another.

Research

1 event

CLAIM-TB4-CELL-MIGRATION

2026-09-20researchchanged our reading

Claim record created

Before

— (no prior state)

After

tracked

Trials

0 events

No trial milestones are indexed to this exact record yet.

Regulatory

0 events

No regulator decisions listed yet.

Real-world reports

0 events

No real-world reports yet — social platforms are not connected.

Section L

Sources

Every study we used. Only studies we confirmed on PubMed are shown as sources. Where a drug is FDA-approved, its official label sits beside them — that is an approval, not a sales pitch.

No official FDA label for this product

We only attach an FDA record when the molecule is an approved drug and we have checked the application number. Most research peptides will stay empty here.

The building blocks, one by one

#CodeResidueClassChiralityFeatures
1SSerinepolarL
2DAspartatenegativeL
3KLysinepositiveL
4PProlinespecialLProline kink
5DAspartatenegativeL
6MMethioninehydrophobicL
7AAlaninehydrophobicL
8EGlutamatenegativeL
9IIsoleucinehydrophobicL
10EGlutamatenegativeL
11KLysinepositiveL
12FPhenylalaninehydrophobicL
13DAspartatenegativeL
14KLysinepositiveL
15SSerinepolarL
16KLysinepositiveL
17LLeucinehydrophobicL
18KLysinepositiveL
19KLysinepositiveL
20TThreoninepolarL
21EGlutamatenegativeL
22TThreoninepolarL
23QGlutaminepolarL
24EGlutamatenegativeL
25KLysinepositiveL
26NAsparaginepolarL
27PProlinespecialLProline kink
28LLeucinehydrophobicL
29PProlinespecialLProline kink
30SSerinepolarL
31KLysinepositiveL
32EGlutamatenegativeL
33TThreoninepolarL
34IIsoleucinehydrophobicL
35EGlutamatenegativeL
36QGlutaminepolarL
37EGlutamatenegativeL
38KLysinepositiveL
39QGlutaminepolarL
40AAlaninehydrophobicL
41GGlycinespecialLflexible
42EGlutamatenegativeL
43SSerinepolarL